1. Introduction
Detection of brain tumors is of great importance in clinical diagnostics and treatment planning, as early localization of neoplastic lesions directly affects prognosis and therapeutic efficacy [
1]. As medical imaging data continues to increase, exploring deep learning-based detection models is encouraged for automated tumor identification [
2]. Such models offer a great potential in mitigating diagnostic workload while enhancing consistency in image interpretation [
3]. Among the diverse deep learning architectures, You Only Look Once (YOLO)-based models have proven effective in medical imaging due to their streamlined detection pipeline enabling real-time inference while preserving an effective trade-off between detection accuracy and computational cost [
4]. Since clinical applications require rapid and reliable results, YOLO-based systems are well-suited for deployment [
5]. YOLOv8 [
6] is a single-stage object detection framework that provides balanced detection accuracy and computational efficiency. It is structured into three primary components: the backbone for feature extraction, the neck for multi-scale feature fusion, and the detection head for final predictions.
The backbone combines standard convolutional layers with a lightweight C2f module to extract hierarchical feature representations from the input image. To enable effective learning with minimal computational burden, the C2f design promotes efficient gradient propagation and feature reuse through dense inter-layer connections. For further capturing of contextual information at multiple receptive fields, a Spatial Pyramid Pooling Fast (SPPF) layer is incorporated at the terminal stage of the backbone, strengthening multi-scale object representation.
The neck integrates Feature Pyramid Network (FPN) [
7] and Path Aggregation Network (PANet) [
8] principles in the intermediate stage, combining low-level spatial details with high-level semantic information. Such bidirectional feature fusion strengthens both shallow and deep feature interactions and allows for improved localization of multi-scale objects.
The detection head employs a decoupled structure, where classification and localization are processed through separate branches, to reduce task interference and enable enhanced prediction stability. Moreover, YOLOv8 simplifies the detection process and improves adaptability to objects exhibiting varying aspect ratios through employing an anchor-free detection strategy.
YOLOv8 leverages advanced loss formulations for optimization. Classification is guided by binary cross-entropy or varifocal loss [
9] that addresses class imbalance, whereas the optimization of bounding box regression is done using Distribution Focal Loss (DFL) combined with Complete IoU (CIoU) loss [
10] for enhanced localization precision. Together, these components underpin the robustness and adaptability of YOLOv8 across varied detection contexts.
Recent studies have enhanced the YOLOv8 architecture to increase detection accuracy, mainly through attention mechanisms, multi-scale feature fusion, and additional detection heads [
11]. In particular, BGF-YOLO [
12], which is an advanced variant, has achieved state-of-the-art results on brain tumor detection benchmarks through the integration of bi-level routing attention [
13], which is an efficient attention mechanism that selectively emphasizes informative, along with Generalized Feature Pyramid Networks (GFPN) [
14] which enhance multi-scale feature fusion via enriched cross-level connections and extended detection heads. This architecture forms the foundation for the present work. However, existing works rely on fixed high-resolution images, often 640 × 640 pixels, and assume the necessity of higher input resolution for reliable tumor detection [
15].
This assumption raises important methodological questions: first, in clinical settings, medical images suffer substantial variability in resolution, acquisition devices, and quality [
16]. Second, high-resolution models have limited applicability in resource-constrained environments as increased computational cost and memory requirements become a concern [
17]. Particularly for subtle tumors, the reduction of input resolution is expected to degrade the detection process [
18]. Mitigation of this degradation through architectural and training-level adjustments remains insufficiently explored [
19].
In YOLO-based tumor detection models, the interaction between resolution scaling and network capacity, such as depth and width, has not been systematically evaluated [
20]. Although model scaling approaches are well established in natural image detection, their potential to compensate for reduced spatial detail in medical imaging applications remains insufficiently explored, as conventional architectural configurations which are successful in natural image pipelines may not directly translate to medical applications and could degrade robustness or sensitivity [
21]. Under reduced-resolution conditions, the combined impact of architectural scaling and training-level optimization has not been clearly established, despite its clinical importance [
22]. Consequently, a significant gap remains in understanding the robustness and adaptability of YOLO-based models in real-time medical imaging scenarios. This study addresses this gap by proposing a resolution-aware optimization framework that improves detection performance while maintaining computational efficiency.
3. Related Work
Due to their end-to-end detection paradigm and real-time inference capacity, YOLO-based detection models have increasingly been transitioned from natural image analysis to specialized medical domains, such as brain tumor localization [
23,
24]. The single-stage architecture of the YOLO series is particularly valued in clinical settings for its ability to provide rapid diagnostic feedback while capturing global contextual information from entire MRI or CT slices [
24,
25]. Recent studies have utilized various iterations, including YOLOv8, YOLOv9, and the newly released YOLOv11, to automate the identification of tumors with high precision [
24,
26,
27].
In addition to performance-driven improvements, recent research trends in medical imaging have increasingly focused on enhancing model interpretability and clinical trust. Explainable artificial intelligence (XAI) techniques have been widely explored, particularly in neurodegenerative disorder analysis, to provide insight into model predictions and improve transparency in decision-making processes [
28,
29].
Architectural enhancements have been pivotal in addressing the unique challenges of medical imaging, such as low contrast and tumor heterogeneity. Researchers have integrated sophisticated attention mechanisms—such as the Convolutional Block Attention Module, Bi-level routing attention, and multi-head self-attention—to prioritize tumor-specific regions and mitigate background noise [
12,
30,
31]. For instance, the BGF-YOLO architecture enhances feature representation by combining generalized feature pyramid networks with a fourth detection head specifically designed for multi-scale tumor detection [
12]. Similarly, the SCC-YOLO model utilizes an SCConv module within a YOLOv9 framework to reduce spatial redundancy and improve feature learning efficiency [
26].
Multi-scale feature fusion and cross-scale strategies have further improved the detection of tumors with diverse sizes and appearances [
31,
32]. Models like CS-YOLO utilize channel shuffling and depthwise separable convolutions to balance detection speed with the ability to recognize complex, heterogeneous targets [
30].
Furthermore, advanced deep learning paradigms such as graph neural networks (GNNs) have been proposed to improve representation learning and generalization, particularly in data-limited scenarios [
33]; for example, unified GNN-based approaches incorporating task-level abstraction and pooling strategies have demonstrated promising performance in few-shot learning tasks, reflecting the growing interest in adaptable and robust learning frameworks in medical imaging [
34]. Despite these advancements, most existing approaches predominantly rely on fixed input resolutions often standardized at 416 × 416 or 640 × 640 pixels and frequently overlook the performance implications of resolution reduction, which can be critical when identifying micro-tumors or working under hardware constraints [
35,
36].
While these approaches focus on improving interpretability, representation learning, and architectural performance under standard conditions, limited attention has been given to the interaction between input resolution and model capacity in medical object detection. In particular, the ability of architectural scaling strategies to compensate for reduced spatial resolution remains insufficiently explored.
Furthermore, scaling strategies involving systematic adjustments to network depth and width have been investigated to optimize the trade-off between accuracy and computational efficiency [
23,
35]. In general object detection, selecting an appropriate backbone size (e.g., from YOLOv8-nano to YOLOv8-large) significantly influences the model’s capacity to extract deep features from low-light or noisy medical images [
23,
35]. However, the specific roles of these scaling strategies under resolution constraints remain scarcely investigated in the context of brain tumor detection, representing a significant gap in the current literature.
5. Experimental Results and Discussion
The findings of this study demonstrate that the performance degradation resulting from input resolution reduction is not inevitable. Although decreasing the image size from 640 × 640 to 480 × 480 initially led to reductions in precision, recall, mAP50, and mAP50–95, this decline can be attributed to the fact that tumor regions in brain MRI scans typically occupy small and irregular areas, making accurate localization highly dependent on spatial detail.
Through progressive architectural scaling and training-level optimization, the proposed framework effectively compensated for the loss of spatial information. The final configuration evaluated on the Br35H dataset [
37] achieved a recall of 0.943 and an mAP
50–95 of 0.672, surpassing the original high-resolution baseline (0.926 recall and 0.653 mAP
50–95), while maintaining competitive mAP
50 performance (0.946). These results confirm that sensitivity and localization robustness can be preserved, and even possibly enhanced, under reduced input size conditions through principled optimization strategies.
To further assess the generalization capability of the proposed model, additional cross-dataset evaluations were conducted. The model was first trained on the primary dataset [
37] and subsequently evaluated on an external dataset [
43] using a randomly selected subset corresponding to approximately 10% of the available validation samples. Only images containing tumor regions were included in this subset. This step was necessary to avoid introducing domain shift factors unrelated to the learned detection task. The evaluation was performed on 53 images.
Despite the limited sample size, the model demonstrated strong performance, achieving a precision of 0.947, recall of 0.927, mAP50 of 0.958, and mAP50–95 of 0.747, further exceeding the original high-resolution baseline. These results highlight the robustness of the model and its ability to generalize to unseen data distributions.
In addition, the model was evaluated on another independent dataset [
44], where a custom data split was applied due to the absence of predefined validation sets. Specifically, 75% of the training data was used for training and 25% for validation, while the provided axialtest set was used for evaluation. In this setting, the model achieved a precision of 0.840, a recall of 0.901, mAP
50 of 0.867, and mAP
50–95 of 0.437. Although the mAP
50–95 localization performance is lower compared to the primary dataset, the model maintained high recall, indicating consistent sensitivity in different datasets with varying characteristics.
In general, these findings demonstrate that the proposed model not only compensates for reduced input size, but also maintains stable and reliable detection performance across multiple datasets. This supports the effectiveness of the proposed optimization strategy and its potential applicability in real-world clinical scenarios with heterogeneous data distributions.
5.1. Effect of Input Resolution Scaling
Table 1 presents the performance comparison between the original high-resolution configuration (640 × 640) and the low-resolution setting (480 × 480) without any architectural or training modifications. Reducing input resolution leads to a consistent decline in all evaluation metrics; in particular, recall drops from 0.926 to 0.869, indicating reduced sensitivity to tumor regions, while mAP
50 and mAP
50–95 decrease by approximately 5% and 3%, respectively, confirming that lower spatial resolution negatively affects both detection accuracy and localization precision. These results establish a challenging baseline and highlight the need for architectural and training-level optimizations to compensate for the loss of spatial detail.
5.2. Impact of Depth Scaling
As shown in
Table 2, increasing network depth improves precision but consistently reduces recall and mAP
50 compared to the reduced-resolution baseline. This behavior is attributed to the increase in the number of repeated convolutional blocks (C2f and CSP) in the backbone and neck stages of the YOLO architecture. This indicates that deeper architectures become more selective, reducing false positives but missing a larger number of tumor regions. This behavior reflects a shift toward conservative detection, which is usually undesirable when clinical priority is sensitivity.
Figure 3 visualizes the response surface of the depth-scaled model across the confidence and IoU threshold combinations evaluated. The four subplots show that increasing depth primarily benefits precision, while recall and the stricter localization metric mAP
50–95 remain limited over large parts of the parameter space. This confirms that depth scaling alone promotes a more selective detector but does not sufficiently recover sensitivity under reduced-resolution conditions.
5.3. Impact of Width Scaling
In object detection tasks, wider networks are generally associated with improved sensitivity to object presence, as they can better represent variations in object appearance. For brain tumor detection, this characteristic is particularly relevant, as tumor regions may exhibit heterogeneous shapes, textures, and intensities across different MRI scans. As shown in
Table 3, width scaling yields improvements in recall, mAP
50, and mAP
50–95 (up to 0.861, 0.909, and 0.664, respectively) relative to depth-only scaling, indicating enhanced sensitivity and localization capability. Due to increased feature-channel diversity and improved spatial representation, however, precision slightly decreases, reflecting a higher rate of false positives. This demonstrates that width expansion improves detection coverage but cannot fully restore performance alone.
The corresponding threshold-dependent behavior is illustrated in
Figure 4. Compared to the depth-scaled configuration, the width-scaled model exhibits a broader region of improved recall and mAP values, indicating better preservation of tumor-sensitive feature representations. At the same time, precision becomes less dominant, which reflects the expected trade-off between sensitivity and selectivity.
5.4. Depth–Width Balanced Configuration
Balanced scaling substantially recovers recall (0.877) while keeping precision stable (0.908). Through the results of increasing depth and width, the balanced configuration (depth = 1.1, width = 1.4) demonstrates that architectural synergy is more effective than isolated scaling. The best mAP
50 (0.935) occurs with a very low conf (0.0001), and mAP
50–95 (0.641) occurs with a very low conf (0.001), demonstrating the effectiveness of coordinated capacity scaling. The results are shown in
Table 4.
To complement the tabulated values,
Figure 5 presents the performance surfaces of the balanced depth–width configuration across the investigated confidence and IoU thresholds. The figure shows a more favorable joint distribution of precision, recall, and localization metrics than the previous single-factor scaling experiments. In particular, the balanced configuration yields a wider region where recall and mAP
50 remain high simultaneously, confirming that coordinated capacity scaling provides a more robust solution than isolated depth or width adjustment.
An analysis of the results presented in the depth and width scaling experiments reveals a clear trade-off between detection precision and sensitivity. As observed from the depth scaling results, increasing the network depth from 1.0 to 1.2 consistently improves precision, indicating a more selective detection behavior with reduced false-positive predictions. However, this improvement comes at the cost of a noticeable reduction in recall and mAP50, suggesting diminished sensitivity to tumor regions, particularly under reduced-resolution conditions. This behavior suggests that deeper architectures tend to favor conservative detection decisions when spatial detail is limited. Conversely, the width scaling experiments demonstrate that a moderate increase in network width leads to improvements in recall, mAP50, and mAP50–95, reflecting enhanced sensitivity and localization capability. This behavior can be attributed to the increased number of feature channels, which enables richer spatial representation and better capture of tumor-related variations. Nevertheless, this improvement is accompanied by a slight reduction in precision, although the resulting precision values remain within an acceptable and competitive range compared to earlier configurations. These observations indicate that width scaling alone improves coverage but does not fully preserve the selectivity achieved through increased depth. These complementary trends confirm that depth and width scaling affect detection performance in fundamentally different but synergistic ways. Depth scaling primarily promotes precision-oriented behaviour, whereas width scaling enhances recall and localization accuracy. Relying on either strategy independently, therefore, leads to an imbalance between selectivity and sensitivity, preventing the model from achieving optimal overall performance under reduced input size. Motivated by this trade-off, a balanced scaling strategy was implemented by moderately reducing the depth scaling factor to 1.1 while further increasing the width scaling factor to 1.4. This configuration was evaluated using the same dataset split, input resolution (480 × 480), and experimental protocol to validate whether harmonizing depth and width could jointly improve detection performance. The balanced depth–width configuration achieves a more favourable compromise between precision and sensitivity compared to isolated depth or width scaling. In particular, recall and mAP50 are improved relative to depth-only scaling, while precision remains competitive and substantially higher than that obtained through aggressive width expansion alone. These findings demonstrate that coordinated depth–width scaling is an effective strategy for mitigating resolution-induced performance degradation while maintaining a balanced detection behavior.
5.5. Effect of MixUp and Dropout
MixUp augmentation and dropout regularization refinement also played a crucial role. They result in the overall localization strictness metric mAP50–95, peaking at 0.692 with (conf = 0.1, IoU = 0.4) and delivering a strong recall of 0.910, as shown in
Table 5. MixUp generates synthetic training samples by linearly combining pairs of images and their corresponding labels, encouraging smoother decision boundaries and improved generalization [
45]. Dropout complements this process by randomly deactivating a fraction of neurons during training, preventing co-adaptation and promoting more generalized feature learning [
46]. This step aims to enhance model generalization and reduce overfitting without altering the network architecture.
A comparative analysis between models trained with and without data augmentation showed that the inclusion of MixUp led to improved performance in terms of mAP50–95 and recall, confirming its effectiveness in enhancing model generalization. Similarly, the use of the AdamW optimizer contributed to more stable convergence and improved detection sensitivity compared to standard optimization settings.
Figure 6 further illustrates the effect of MixUp augmentation and dropout regularization across the evaluated threshold pairs. Compared with the balanced architecture alone, the regularized configuration produces a more favorable mAP
50–95 landscape and preserves strong recall in a wider operating region. This behavior suggests that the training-level regularization improves generalization and stabilizes localization performance under reduced-resolution conditions.
5.6. Optimizer and Learning Rate Comparison
Switching to AdamW produced the strongest recall values in the 480 × 480 study. As shown in
Table 6, a higher learning rate (
) can yield higher precision (up to 0.978), but with a substantial recall penalty (0.779), which is difficult to justify when the clinical priority is sensitivity and localization accuracy. In contrast, the best overall balance was achieved at
, with a maximum recall of 0.943 and mAP
50–95 of 0.672, as shown in
Table 7. These results suggest that detection robustness under reduced resolution depends on joint architectural and optimization strategies, rather than increased input size alone.
The threshold-dependent behavior of the final AdamW-based configuration is shown in
Figure 7, demonstrating that the optimized training strategy produces a broad high-performing region, especially in recall and mAP
50–95. These results confirm that the AdamW optimizer together with the tuned learning-rate schedule contributes substantially to the recovery of reduced-resolution performance. Notably, the best-performing region is centered around moderate IoU and confidence settings, indicating stable and clinically relevant operating conditions.
5.7. Summary of Study
Table 8 summarizes the best-performing configuration obtained at each stage of the proposed optimization pipeline and highlights the final model performance relative to the original baseline. The reference model evaluated at 640 × 640 achieves a recall of 0.926 and an mAP
50–95 of 0.653. In contrast, the final optimized configuration under reduced resolution (480 × 480) attains a higher recall of 0.943 and an improved mAP
50–95 of 0.672, demonstrating that the proposed optimization strategy not only compensates for the loss of spatial resolution but also surpasses the original baseline in key performance indicators. These results confirm that progressive architectural scaling, regularization, and optimizer refinement collectively enhance detection sensitivity and localization reliability. In medical imaging applications, false negatives are often more critical than false positives. The superior recall achieved by the proposed method relative to several state-of-the-art models demonstrates its potential suitability for clinical screening scenarios. Although certain transformer-based detectors report slightly higher mAP
50–95 values, the proposed framework maintains competitive localization accuracy while offering enhanced sensitivity. Achieving higher recall and mAP
50–95 than the original high-resolution configuration highlights the effectiveness of the proposed framework in maintaining clinical sensitivity and localization accuracy, even under reduced-resolution constraints.
To further interpret these results, an ablation-style analysis of the optimization pipeline is provided, explicitly quantifying the contribution of each component to the recovery of detection performance under reduced-resolution conditions. Starting from the reduced baseline 480 × 480, depth scaling increased precision but reduced recall, indicating a more conservative detection behavior. Width scaling partially compensated for this by improving recall and mAP-related metrics due to enhanced feature representation capacity. The introduction of balanced depth–width scaling further improved both precision and recall, demonstrating that coordinated architectural scaling is more effective than isolated adjustments. Subsequent application of MixUp augmentation and dropout regularization improved generalization and localization robustness, as reflected by increased mAP50–95 values. Finally, the use of the AdamW optimizer with a lower learning rate (lr0 = 0.0001) resulted in the most significant improvement in recall and overall detection stability. This step played a critical role in enabling the reduced-resolution model to match and, in some cases, surpass the high-resolution baseline.
5.8. Qualitative Detection Results
Figure 8 presents representative qualitative detection results on brain MRI images, comparing ground-truth annotations (A) with the predicted model outputs (B). The first example demonstrates accurate localization of a large, high-contrast tumor region, where the predicted bounding box closely overlaps the annotated ground-truth box (
), indicating reliable spatial detection.
The second example highlights the model’s sensitivity to small lesions. Despite the relatively limited tumor area, the model successfully identifies the tumor and produces a well-centered bounding box with a high confidence score ().
The third example illustrates performance on a complex tumor appearance, where the model detects the main tumor region and additionally captures an internal or sub-region component, reflecting robustness to heterogeneous tumor morphology and intra-tumoral structural variations. This behavior suggests effective training, as some training samples contain overlapping tumors, as illustrated in
Figure 1.
In general, these examples confirm that the proposed configuration maintains accurate tumor localization across varying tumor sizes and appearance patterns.
Tumor size variation is a critical factor in brain tumor detection, particularly under reduced-resolution conditions. Small lesions are more sensitive to resolution reduction due to the loss of fine spatial details, whereas larger tumors remain more detectable due to their prominent spatial characteristics. This effect becomes more evident when comparing different input resolutions, where higher-resolution inputs (640 × 640) preserve finer details that improve the detection of small or low-contrast tumor regions, while reduced-resolution inputs (480 × 480) may lead to slight localization coarseness. Despite this limitation, the proposed optimization strategy helps to avoid performance degradation by enhancing feature representation and improving detection sensitivity, as reflected in both quantitative results and the qualitative examples shown in
Figure 8. These qualitative results further indicate that, although smaller tumors are more sensitive to reduced spatial resolution, the proposed model maintains effective detection performance across different tumor sizes.
5.9. The Training Configuration
Data augmentation was applied using MixUp with a mixing ratio of 0.1 to improve generalization and robustness. This approach combines pairs of training samples to enhance feature diversity and reduce overfitting. The model was trained for 120 epochs using an NVIDIA GeForce RTX 4060 Laptop GPU.
Figure 4 illustrates the progression of the model’s key performance metrics during the training process, including precision, recall, mAP
50, and mAP
50–95 across training epochs.
All metrics demonstrate rapid improvement during the early epochs, indicating the model’s ability to effectively learn the discriminative features of brain tumors in the initial stages of training. Subsequently, the curves gradually stabilize, reflecting convergence without significant fluctuations.
Precision increases to a high level and stabilizes toward the end of training, suggesting a reduction in false-positive detections. Recall also shows a steady upward trend, indicating that the model successfully identifies most true tumor instances.
The mAP50 achieves high values, reflecting strong detection performance under moderate IoU criteria. In contrast, mAP50–95 is comparatively lower, as expected, due to the stricter overlap requirements. Nevertheless, it exhibits a consistent upward trend, demonstrating improved tumor region localization accuracy.
Overall, the
Figure 9 indicates stable convergence and robust learning behavior, with no clear signs of overfitting during the training phase.
In addition to detection performance, computational efficiency is an important factor in real-world deployment, particularly in clinical environments where rapid inference and limited hardware resources are common. Reducing the input resolution from 640 × 640 to 480 × 480 decreases the number of input pixels by approximately 44%, leading to a proportional reduction in computational cost. This reduction is expected to improve inference speed and lower GPU memory consumption, enabling faster processing and making the proposed model more suitable for real-time or resource-constrained applications.
5.10. Comparative Results
Table 9 presents a quantitative comparison between the proposed method and several recent state-of-the-art brain tumor detection models evaluated on the Br35H dataset [
37]. Although the proposed framework operates at a reduced input resolution of 480 × 480 it achieves highly competitive and, in certain aspects, superior performance compared to models trained at 640 × 640 resolution.
In terms of recall, the proposed method attains 0.943, surpassing YOLOv8x (0.881), YOLOv9e (0.869), YOLOv10x (0.808), BGF-YOLO (0.926), RCS-YOLO (0.885), STAR-YOLO (0.852), YOLOv10-TL (0.927), and PK-YOLO (0.896), while remaining comparable to OS-DETR (0.942). This demonstrates enhanced sensitivity in tumor detection, a particularly important factor in clinical applications where minimizing missed tumor regions is critical.
Regarding mAP50–95, which reflects stricter localization performance across multiple IoU thresholds, the proposed method achieves 0.672, outperforming the original BGF-YOLO baseline (0.653), YOLOv8x (0.646), YOLOv9e (0.630), YOLOv10x (0.603), RCS-YOLO (0.580), and STAR-YOLO (0.642). Although OS-DETR (0.742) and YOLOv10-TL (0.739) report higher values, these models operate at higher input resolutions and increased computational capacity.
For mAP50, the proposed method achieves 0.946, outperforming YOLOv8x (0.927), YOLOv9e (0.919), YOLOv10x (0.880), and RCS-YOLO (0.878), while closely matching PK-YOLO (0.947) and remaining competitive with higher-resolution detectors. This indicates that reducing input resolution does not substantially compromise detection accuracy at the standard IoU threshold.
While precision (0.858) is slightly lower than some transformer-based or transfer-learning-enhanced models, it remains within an acceptable and competitive range, particularly considering the model’s emphasis on sensitivity.
Overall, the results indicate that the proposed optimization strategy effectively balances detection sensitivity and localization accuracy under reduced-resolution constraints. The model demonstrates superior recall and competitive mAP performance compared to several 640 × 640-based detectors, highlighting the effectiveness of progressive architectural scaling and optimizer refinement.
6. Conclusions
This study systematically investigated the effect of input resolution scaling on brain tumor detection performance using an optimized YOLO-based framework. Although reducing the input resolution from 640 × 640 to 480 × 480 initially led to performance degradation, the proposed progressive optimization strategy successfully compensated for the loss of spatial detail through coordinated depth–width scaling, regularization, and optimizer refinement. The normalized performance surfaces of the final AdamW-optimized model, shown in
Figure A1, illustrate the relative improvement with respect to the 480 × 480 baseline, where values above 1 indicate performance gains over the reduced-resolution reference.
The final configuration achieved a recall of 0.943, surpassing the original high-resolution baseline (0.926) and several recent state-of-the-art detectors. Moreover, the model attained an mAP
50–95 of 0.672, exceeding the original baseline (0.653) and outperforming multiple competing approaches evaluated at higher resolutions. As further illustrated in
Figure A2, the normalized performance surfaces relative to the original 640 × 640 baseline demonstrate that the optimized reduced-resolution model approaches or, in some cases, exceeds the high-resolution reference, with values near or above 1 indicating comparable or improved performance.
Although the dataset size used in this study is relatively limited, the experiments were conducted under controlled conditions with fixed data splits to ensure consistency. To further address this limitation and evaluate the generalization capability of the proposed model, additional cross-dataset experiments were conducted using a randomly selected subset (approximately 10% of the available test samples) from an external dataset. The model demonstrated consistent performance, achieving an mAP50–95 of 0.747 with a high recall of 0.927, indicating strong robustness beyond the primary evaluation dataset.
Furthermore, evaluation on another independent dataset using a custom training–validation split (75–25%) yielded stable performance, with recall reaching 0.901, confirming the model’s ability to maintain detection sensitivity across varying data distributions.
Importantly, these results were obtained under reduced-resolution conditions, demonstrating that effective architectural and training-level tuning can preserve and even enhance localization robustness without increasing input size.
While the proposed model demonstrates strong generalization across multiple brain tumor datasets, the evaluation remains within the same application domain. Nevertheless, the underlying optimization strategy is not task-specific and may be applicable to other medical object detection tasks, particularly those involving small or heterogeneous targets. However, further validation on diverse medical datasets is required to fully establish generalizability.
Overall, the proposed framework highlights that sensitivity-oriented and localization-consistent brain tumor detection can be achieved efficiently at lower resolution. This finding suggests that performance improvements in medical object detection do not necessarily require larger input sizes but, rather, principled optimization of model capacity and training dynamics.